Table 3.

Association between day-14 donor chimerism levels and graft rejection


% Donor chimerism on day 14

No. of patients with rejection/no. patients at risk* (%)
T cells
NK cells
Monocytes
Granulocytes
0 to 25   4/9 (44)   5/9 (56)   5/18 (28)   6/66 (9)  
26 to 50   4/23 (17)   1/9 (11)   0/21   2/15 (13)  
51 to 75   1/40 (2.5)   1/19 (5)   1/28 (4)   0/4 (0)  
76 to 90   0/22 (0)   0/35 (0)   0/15 (0)   0/6 (0)  
91 to 100
 
0/6 (0)
 
0/14 (0)
 
0/10 (0)
 
0/5 (0)
 

% Donor chimerism on day 14

No. of patients with rejection/no. patients at risk* (%)
T cells
NK cells
Monocytes
Granulocytes
0 to 25   4/9 (44)   5/9 (56)   5/18 (28)   6/66 (9)  
26 to 50   4/23 (17)   1/9 (11)   0/21   2/15 (13)  
51 to 75   1/40 (2.5)   1/19 (5)   1/28 (4)   0/4 (0)  
76 to 90   0/22 (0)   0/35 (0)   0/15 (0)   0/6 (0)  
91 to 100
 
0/6 (0)
 
0/14 (0)
 
0/10 (0)
 
0/5 (0)
 

P values were obtained from trend test in a logistic regression model after adjusting for presence of unrelated donor: T cells, P = .003; NK cells, P = .004; monocytes, P = .02; and granulocytes, P = .22.

Day-14 T-cell, NK-cell, monocyte, and granulocyte chimerism data were available for 100, 86, 92, and 96 patients, respectively.

or Create an Account

Close Modal
Close Modal